Patent · US Expired

Microencapsulated and controlled-release formulations of isoflavone from enriched fractions of soy and other plants

US6890561B1 · kind B1 · utility

52Cited by
13References
32Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 15, 2000
Grant dateMay 10, 2005
Priority date
Expiry dateMar 18, 2021

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/352
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

There is provided an orally-administrable formulation for the controlled release or stable storage of a granulated isoflavone-enriched fraction or mixture of such fractions, comprising at least one granulated isoflavone-enriched fraction and at least one carrier, diluent or excipient therefor. Preferably, the formulation is characterized in that the total in vitro dissolution time of said formulation required for release of 75% of the active ingredients available from the formulation is between about 4 and about 18 hours, as determined by the U.S.P. XXIII paddle method at a paddle speed of 75 rpm, using simulated intestinal fluid without the digestive enzymes normally found in intestinal fluid, at pH 6.8, and a temperature of 37° C. A process for the preparation of such a formulation is also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.